APA-viite

Vincenzi, B., Trower, M., Duggal, A., Guglielmini, P., Harris, P., Jackson, D., . . . Ständer, S. (2020). Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: A randomised, placebo-controlled phase II trial. BMJ Open.

Chicago-tyylinen lähdeviittaus

Vincenzi, Bruno, et al. "Neurokinin-1 Antagonist Orvepitant for EGFRI-induced Pruritus in Patients With Cancer: A Randomised, Placebo-controlled Phase II Trial." BMJ Open 2020.

MLA-viite

Vincenzi, Bruno, et al. "Neurokinin-1 Antagonist Orvepitant for EGFRI-induced Pruritus in Patients With Cancer: A Randomised, Placebo-controlled Phase II Trial." BMJ Open 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.